| Literature DB >> 33884263 |
Nilsu İnönü-Sakallı1, Cemal Sakallı2, Özgür Tosun3, Damla Akşit-Bıçak1.
Abstract
We aimed to investigate the oral health of children in terms of the presence of dental caries, periodontal health, halitosis, and dentofacial changes in patients who had adenotonsillar hypertrophy related to mouth breathing and compared these findings with nasal breathing healthy and adenotonsillectomy-operated children. The patient group comprised 40 mouth-breathing children who were diagnosed with adenotonsillar hypertrophy, while the control group consisted of 40 nasal breathing children who had no adenotonsillar hypertrophy. Forty children who had undergone an adenotonsillectomy operation at least 1 year prior to the study were included in the treatment group. Oral examinations of all children were conducted, and the parents were asked about medical and dental anamnesis, demographic parameters, toothbrushing and nutrition habits, oral health-related quality of life (OHRQoL), and symptoms of their children. Demographic parameters, toothbrushing and nutrition habits, and the presence of bad oral habits did not differ between groups (p > 0.05). Adenotonsillectomy is associated with a remarkable improvement in symptoms; however, some symptoms persist in a small number of children. The salivary flow rate, dmft/s, DMFT/S index, plaque, and gingival index scores did not differ between groups (p > 0.05). The patient group showed higher rates of halitosis when compared with the treatment and control groups (p < 0.001). Mouth breathing due to adenotonsillar hypertrophy caused various dentofacial changes and an increase in Class II division 1 malocclusion (p < 0.001). It was shown that adenotonsillar hypertrophy does not negatively affect OHRQoL, it could be a risk factor for dental caries, periodontal diseases, and halitosis, but by ensuring adequate oral health care, it is possible to maintain oral health in children with adenotonsillar hypertrophy. Also, it is recommended that orthodontic treatment should start as soon as possible if it is required. In this context, otorhinolaryngologists, pedodontists, and orthodontists should work as a team in the treatment of children with adenotonsillar hypertrophy.Entities:
Year: 2021 PMID: 33884263 PMCID: PMC8041545 DOI: 10.1155/2021/5550267
Source DB: PubMed Journal: Biomed Res Int Impact factor: 3.411
Demographic parameters.
| Patient group ( | Treatment group ( | Control group ( |
| ||
|---|---|---|---|---|---|
| Gender ( | Girl | 17 (42.5%) | 18 (45.0%) | 18 (45.0%) | 0.9671 |
| Boy | 23 (57.5%) | 22 (55.0%) | 22 (55.0%) | ||
| Age | Mean | 7.35 | 8.075 | 8.075 | 0.2842 |
| SD | 3.5486 | 2.8946 | 2.8946 | ||
| SE | 0.56108 | 0.45768 | 0.45768 | ||
| Family income ( | 3.000–6.000 ₺ | 10 (25.0%) | 3 (7.5%) | 7 (17.5%) | 0.2621 |
| 6.000–9.000 ₺ | 15 (37.5%) | 15 (37.5%) | 13 (32.5%) | ||
| ≥10.000 ₺ | 15 (37.5%) | 22 (55.0%) | 20 (50.0%) | ||
| Parental education level ( | Primary school | 2 (5.0%) | 1 (2.5%) | 0 (0.0%) | 0.0983 |
| Middle school | 4 (10.0%) | 1 (2.5%) | 3 (7.5%) | ||
| High school | 12 (30.0%) | 6 (15.0%) | 10 (25.0%) | ||
| University | 17 (42.5%) | 26 (65.0%) | 20 (50.0%) | ||
| Master degree | 5 (12.5%) | 5 (12.5%) | 5 (12.5%) | ||
| Doctorate degree | 0 (0.0%) | 1 (2.5%) | 2 (5.0%) | ||
| Previous dental visit ( | Yes | 17 (42.5%) | 25 (62.5%) | 33 (82.5%) | 0.0011 |
| No | 23 (57.5%) | 15 (37.5%) | 7 (17.5%) |
1Pearson's Chi-squared test, 2Kruskal Wallis Test, and 3Trend test for ordinal variables.
Symptoms of patient and treatment groups.
| Patient group ( | Treatment group ( |
| |
|---|---|---|---|
| Tasting difficulty | 3 (7.5%) | 0 (0.0%) | 0.077 |
| Smelling difficulty | 6 (15.0%) | 3 (7.5%) | 0.288 |
| Speaking difficulty | 18 (45.0%) | 13 (32.5%) | 0.251 |
| Difficulty in swallowing | 21 (52.5%) | 4 (10.0%) | <0.001 |
| Abnormal breathing | 33 (82.5%) | 2 (5.0%) | <0.001 |
| Hyperactivity | 23 (57.5%) | 22 (55.0%) | 0.822 |
| Lack of attention | 22 (55.0%) | 18 (45.0%) | 0.371 |
| Aggression | 19 (47.5%) | 15 (37.5%) | 0.366 |
| Headache | 5 (12.5%) | 3 (7.5%) | 0.456 |
| Bedwetting | 2 (5.0%) | 0 (0.0%) | 0.152 |
| Dry mouth | 36 (90.0%) | 9 (22.5%) | <0.001 |
| Thirsty awakening at nights | 36 (90.0%) | 5 (12.5%) | <0.001 |
| Salivate on the pillow during sleeping | 35 (87.5%) | 7 (17.5%) | <0.001 |
| Negative affection of school performance | 5 (12.5%) | 2 (5.0%) | 0.235 |
| Restless sleep | 30 (75.0%) | 3 (7.5%) | <0.001 |
| Daytime somnolence | 15 (37.5%) | 2 (5.0%) | <0.001 |
| Open mouth during sleeping | 37 (92.5%) | 15 (37.5%) | <0.001 |
| Snoring | 40 (100.0%) | 4 (10.0%) | <0.001 |
| Mouth breathing | 40 (100.0%) | 3 (7.5%) | <0.001 |
Pearson's Chi-squared test.
Toothbrushing and nutrition habits.
| Patient group ( | Treatment group ( | Control group ( |
| ||
|---|---|---|---|---|---|
| Toothbrushing frequency | At least once a day | 36.0 (90.0%) | 32.0 (80.0%) | 33.0 (82.5%) | 0.444 |
| Several times a week or never | 4.0 (10.0%) | 8.0 (20.0%) | 7.0 (17.5%) | ||
| Supervised toothbrushing | Generally | 13.0 (32.5%) | 11.0 (27.5%) | 19.0 (47.5%) | 0.152 |
| Occasionally or never | 27.0 (67.5%) | 29.0 (72.5%) | 21.0 (52.5%) | ||
| Used toothpaste | Nonfluoridated | 1.0 (2.5%) | 2.0 (5.0%) | 5.0 (12.5%) | 0.175 |
| Fluoridated | 39.0 (97.5%) | 38.0 (95.0%) | 35.0 (87.5%) | ||
| Nutrition habits | Milk and milk products | ||||
| Less than once a week | 4.0 (10.0%) | 4.0 (10.0%) | 7.0 (17.5%) | 0.504 | |
| At least once a day | 36.0 (90.0%) | 36.0 (90.0%) | 33.0 (82.5%) | ||
| Fruits and vegetables | |||||
| Less than once a week | 1.0 (2.5%) | 5.0 (12.5%) | 1.0 (2.5%) | 0.088 | |
| At least once a day | 39.0 (97.5%) | 35.0 (87.5%) | 39.0 (97.5%) | ||
| Carbonated beverages | |||||
| Less than once a week | 26.0 (65.0%) | 30.0 (75.0%) | 32.0 (80.0%) | 0.303 | |
| At least once a day | 14.0 (35.0%) | 10.0 (25.0%) | 8.0 (20.0%) | ||
| Chocolate and biscuits | |||||
| Less than once a week | 7.0 (17.5%) | 7.0 (17.5%) | 8.0 (20.0%) | 0.946 | |
| At least once a day | 33.0 (82.5%) | 33.0 (82.5%) | 32.0 (80.0%) | ||
| Chips and snacks | |||||
| Less than once a week | 18.0 (45.0%) | 24.0 (60.0%) | 26.0 (65.0%) | 0.171 | |
| At least once a day | 22.0 (55.0%) | 16.0 (40.0%) | 14.0 (35.0%) | ||
| Candy and lollipops | |||||
| Less than once a week | 18.0 (45.0%) | 31.0 (77.5%) | 26.0 (65.0%) | 0.010 | |
| At least once a day | 22.0 (55.0%) | 9.0 (22.5%) | 14.0 (35.0%) |
Pearson's Chi-squared test.
Assessment of caries index, plaque index, and gingival index.
| Group |
| Mean | SD | SE |
| |
|---|---|---|---|---|---|---|
| Salivary flow rate | Patient | 40 | 0.73 | 0.5441 | 0.08602 | 0.377 |
| Treatment | 40 | 0.6325 | 0.4548 | 0.07191 | ||
| Control | 40 | 0.7725 | 0.5435 | 0.08593 | ||
| dmft | Patient | 33 | 2.51515 | 2.9593 | 0.51515 | 0.288 |
| Treatment | 35 | 2.62857 | 2.8808 | 0.48695 | ||
| Control | 34 | 3.58824 | 3.1249 | 0.53591 | ||
| dmfs | Patient | 33 | 3.69697 | 4.74 | 0.82513 | 0.338 |
| Treatment | 35 | 3.45714 | 4.154 | 0.70215 | ||
| Control | 34 | 4.91176 | 4.6343 | 0.79478 | ||
| DMFT | Patient | 23 | 1.73913 | 2.4162 | 0.50381 | 0.124 |
| Treatment | 29 | 0.82759 | 1.3646 | 0.2534 | ||
| Control | 32 | 0.4375 | 0.9483 | 0.16763 | ||
| DMFS | Patient | 23 | 2.26087 | 3.2783 | 0.68357 | 0.145 |
| Treatment | 29 | 1 | 1.5584 | 0.28939 | ||
| Control | 32 | 0.625 | 1.4756 | 0.26085 | ||
| Plaque index | Patient | 40 | 0.145 | 0.2025 | 0.03202 | 0.176 |
| Treatment | 40 | 0.14185 | 0.1616 | 0.02555 | ||
| Control | 40 | 0.0868 | 0.0984 | 0.01555 | ||
| Gingival index | Patient | 40 | 0.00432 | 0.0162 | 0.00256 | 0.134 |
| Treatment | 40 | 0.02732 | 0.069 | 0.01091 | ||
| Control | 40 | 0.02113 | 0.05 | 0.00791 |
Kruskal Wallis Test.
Assessment of halitosis.
| Patient group ( | Treatment group ( | Control group ( |
| |
|---|---|---|---|---|
| Organoleptic measurement | ||||
| No or barely noticeable odor | 0.0 (0.0%) | 21.0 (52.5%) | 24.0 (60.0%) | <0.001 |
| Weak but clearly noticeable odor | 27.0 (67.5%) | 8.0 (20.0%) | 8.0 (20.0%) | |
| Moderate or strong odor | 13.0 (32.5%) | 11.0 (27.5%) | 8.0 (20.0%) | |
| Parental perception of odor in the child | ||||
| Yes | 39.0 (97.5%) | 19.0 (47.5%) | 14.0 (35.0%) | <0.001 |
| No | 1.0 (2.5%) | 21.0 (52.5%) | 26.0 (65.0%) |
Pearson's Chi-squared test.
Assessment of oral bad habits.
| Patient group ( | Treatment group ( | Control group ( |
| |
|---|---|---|---|---|
| Tongue thrusting | 3.0 (7.5%) | 0.0 (0.0%) | 0.0 (0.0%) | 0.0461 |
| Lip sucking | 3.0 (7.5%) | 1.0 (2.5%) | 1.0 (2.5%) | 0.4341 |
| Lip biting | 2.0 (5.0%) | 1.0 (2.5%) | 0.0 (0.0%) | 0.3591 |
| Nail biting | 5.0 (12.5%) | 2.0 (5.0%) | 2.0 (5.0%) | 0.3391 |
| Bruxism | 9.0 (22.5%) | 5.0 (12.5%) | 2.0 (5.0%) | 0.0691 |
Pearson's Chi-squared test.
Assessment of dentofacial findings.
| Patient group ( | Treatment group ( | Control group ( |
| |
|---|---|---|---|---|
| V-shaped narrowing in the maxillary arch | 38.0 (95.0%) | 38.0 (95.0%) | 0.0 (0.0%) | <0.001 |
| Adenoid face | 38.0 (95.0%) | 30.0 (75.0%) | 0.0 (0.0%) | <0.001 |
| Teeth crowding | 12.0 (30.0%) | 17.0 (42.5%) | 7.0 (17.5%) | 0.051 |
| Macroglossia | 26.0 (65.0%) | 27.0 (67.5%) | 5.0 (12.5%) | <0.001 |
| Open mouth posture | 33.0 (82.5%) | 27.0 (67.5%) | 4.0 (10.0%) | <0.001 |
| Anterior and lower tongue position | 26.0 (65.0%) | 25.0 (62.5%) | 0.0 (0.0%) | <0.001 |
| Dry, chapped lips | 37.0 (92.5%) | 7.0 (17.5%) | 1.0 (2.5%) | <0.001 |
| Position of mandibula | ||||
| Normal | 0.0 (0.0%) | 9.0 (22.5%) | 35.0 (87.5%) | <0.001 |
| Prognatic | 3.0 (7.5%) | 1.0 (2.5%) | 4.0 (10.0%) | |
| Retrognatic | 37.0 (92.5%) | 30.0 (75.0%) | 1.0 (2.5%) | |
| Position of maxillary anterior teeth | ||||
| Normal | 25.0 (62.5%) | 22.0 (55.0%) | 37.0 (92.5%) | <0.001 |
| Prominent | 15.0 (37.5%) | 18.0 (45.0%) | 3.0 (7.5%) | |
| Position of mandibular anterior teeth | ||||
| Normal | 20.0 (50.0%) | 30.0 (75.0%) | 39.0 (97.5%) | <0.001 |
| Retrognatic | 20.0 (50.0%) | 10.0 (25.0%) | 1.0 (2.5%) | |
| Dentition period | ||||
| Primary dentition | 16.0 (40.0%) | 10.0 (25.0%) | 6.0 (15.0%) | 0.111 |
| Mixed dentition | 17.0 (42.5%) | 23.0 (57.5%) | 28.0 (70.0%) | |
| Permanent dentition | 7.0 (17.5%) | 7.0 (17.5%) | 6.0 (15.0%) |
Pearson's Chi-squared test.
Assessment of interarch dental occlusal relationship.
| Patient group ( | Treatment group ( | Control group ( |
| |
|---|---|---|---|---|
| Sagittal relationship | ||||
| Normal occlusion | 6.0 (21.4%) | 9.0 (30.0%) | 20.0 (58.8%) | <0.001 |
| Class I malocclusion | 4.0 (14.3%) | 6.0 (20.0%) | 10.0 (29.4%) | |
| Class II division 1 malocclusion | 18.0 (64.3%) | 15.0 (50.0%) | 4.0 (11.8%) | |
| Transversal relationship | ||||
| Posterior crossbite | 9.0 (22.5%) | 10.0 (25.0%) | 5.0 (12.5%) | 0.335 |
| Normal, no crossbite | 31.0 (77.5%) | 30.0 (75.0%) | 35.0 (87.5%) | |
| Vertical relationship | ||||
| Normal overbite | 20.0 (50.0%) | 18.0 (45.0%) | 23.0 (57.5%) | 0.244 |
| Anterior open bite | 8.0 (20.0%) | 11.0 (27.5%) | 3.0 (7.5%) | |
| Deep bite | 12.0 (30.0%) | 11.0 (27.5%) | 14.0 (35.0%) |
Pearson's Chi-squared test.
Assessment of OHRQoL-ECOHIS scale.
| Group | Mean | SD | SE |
| |
|---|---|---|---|---|---|
| Child impact section | |||||
| Child symptoms | Patient | 0.95 | 1.319 | 0.209 | 0.984 |
| Treatment | 1.03 | 1.387 | 0.219 | ||
| Control | 1.05 | 1.518 | 0.240 | ||
| Total | 1.01 | 1.399 | 0.128 | ||
| Child function | Patient | 2.15 | 3.363 | 0.532 | 0.816 |
| Treatment | 2.65 | 3.634 | 0.575 | ||
| Control | 2.45 | 3.404 | 0.538 | ||
| Total | 2.42 | 3.446 | 0.315 | ||
| Child psychology | Patient | 0.48 | 1.261 | 0.199 | 0.936 |
| Treatment | 0.60 | 1.516 | 0.240 | ||
| Control | 0.53 | 1.519 | 0.240 | ||
| Total | 0.53 | 1.426 | 0.130 | ||
| Child self-image and social interaction | Patient | 1.90 | 1.809 | 0.286 | 0.049∗ |
| Treatment | 1.48 | 2 | 0.316 | ||
| Control | 0.98 | 1.459 | 0.231 | ||
| Total | 1.45 | 1.796 | 0.164 | ||
| Total child score | Patient | 5.48 | 6.869 | 1.086 | 0.519 |
| Treatment | 5.75 | 7.2 | 1.138 | ||
| Control | 5 | 6.887 | 1.089 | ||
| Total | 5.41 | 6.935 | 0.633 | ||
| Family impact section | |||||
| Parental distress | Patient | 0.65 | 1.494 | 0.236 | 0.494 |
| Treatment | 1.23 | 2.270 | 0.359 | ||
| Control | 1.13 | 2.09 | 0.330 | ||
| Total | 1 | 1.979 | 0.181 | ||
| Family function | Patient | 0.30 | 0.883 | 0.140 | 0.255 |
| Treatment | 0.55 | 1.154 | 0.182 | ||
| Control | 0.73 | 1.502 | 0.237 | ||
| Total | 0.53 | 1.209 | 0.110 | ||
| Total parent score | Patient | 0.95 | 2.309 | 0.365 | 0.402 |
| Treatment | 1.78 | 3.363 | 0.532 | ||
| Control | 1.85 | 3.446 | 0.545 | ||
| Total | 1.53 | 3.084 | 0.282 | ||
| Total ECOHIS score | Patient | 6.43 | 8.918 | 1.410 | 0.690 |
| Treatment | 7.53 | 10.163 | 1.607 | ||
| Control | 6.85 | 9.991 | 1.580 | ||
| Total | 6.93 | 9.635 | 0.880 |
Kruskal Wallis Test.